Efficacy and safety of long‐term use of tedizolid in disseminated nocardiosis after heart transplantation

José Luis del Pozo has been a consultant for Pfizer, MSD, Gilead, and Novartis. The rest of the authors declare no conflict of interest. The data that support the findings of this study are available from the corresponding author upon reasonable request.